| Dr Jaeha Song, DPM | |
|
2075 S Cottonwood Dr, Tempe, AZ 85282-3040 | |
| (480) 718-0568 | |
| Not Available |
| Full Name | Dr Jaeha Song |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 12 Years |
| Location | 2075 S Cottonwood Dr, Tempe, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700292877 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Livi Medical Services Llc | 8820283039 | 23 |
News Archive
Maxygen, Inc., a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009.
A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.
What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic - circulating in the general population - and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
A strain in ICU capacity has been linked to adverse patient outcomes. New research to be presented at CHEST Congress 2019 Thailand suggests that near-simultaneous ICU admissions are frequent and may also have an adverse effect on patient outcomes.
› Verified 7 days ago
| Provider Name | Livi Medical Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457667750 PECOS PAC ID: 8820283039 Enrollment ID: O20101113000222 |
News Archive
Maxygen, Inc., a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009.
A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.
What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic - circulating in the general population - and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
A strain in ICU capacity has been linked to adverse patient outcomes. New research to be presented at CHEST Congress 2019 Thailand suggests that near-simultaneous ICU admissions are frequent and may also have an adverse effect on patient outcomes.
› Verified 7 days ago
| Provider Name | Integrated Premier Group Specialty Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770961914 PECOS PAC ID: 0446537096 Enrollment ID: O20170508002145 |
News Archive
Maxygen, Inc., a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009.
A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.
What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic - circulating in the general population - and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
A strain in ICU capacity has been linked to adverse patient outcomes. New research to be presented at CHEST Congress 2019 Thailand suggests that near-simultaneous ICU admissions are frequent and may also have an adverse effect on patient outcomes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaeha Song, DPM 2075 S Cottonwood Dr, Tempe, AZ 85282-3040 Ph: (480) 718-0568 | Dr Jaeha Song, DPM 2075 S Cottonwood Dr, Tempe, AZ 85282-3040 Ph: (480) 718-0568 |
News Archive
Maxygen, Inc., a biopharmaceutical company focused on the development of improved versions of protein drugs, today announced that it has extended the expiration date for its modified "Dutch Auction" tender offer to repurchase 6,557,377 shares of its common stock, which was commenced on November 13, 2009.
A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.
What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic - circulating in the general population - and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
A strain in ICU capacity has been linked to adverse patient outcomes. New research to be presented at CHEST Congress 2019 Thailand suggests that near-simultaneous ICU admissions are frequent and may also have an adverse effect on patient outcomes.
› Verified 7 days ago
Dr. Daniel Saunders, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3231 S Country Club Way, Ste 108, Tempe, AZ 85282 Phone: 480-831-0700 Fax: 480-831-0748 | |
Dr. Patrick Gillihan, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6301 S Mcclintock Dr Ste 115, Tempe, AZ 85283 Phone: 480-775-8460 Fax: 480-775-8464 | |
Priyanka Begur, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 800-233-3264 | |
Dr. Sondema Nkipmo Tarr, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4685 S Ash Ave # Siteh1, Tempe, AZ 85282 Phone: 602-638-2718 | |
Dr. Sina Safar, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1840 E Baseline Rd Ste A1, Tempe, AZ 85283 Phone: 480-718-5400 Fax: 877-666-4624 | |
Metro Foot & Ankle Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 3231 S Country Club Way, Suite 108, Tempe, AZ 85282 Phone: 480-831-0700 Fax: 480-831-0748 | |
Direct Podiatry Arizona Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4685 S Ash Ave # Siteh1, Tempe, AZ 85282 Phone: 602-638-2718 |